More Review-Streamliners Introduced In US House: Can They Beat User-Fee Buzzer?
Two more bills were introduced in the House this week to streamline US FDA device review. Its late in the game, but device lobbyists are not completely ruling out attachments to must-pass user-fee bills. Also, check out our table rounding up FDA medtech reform bills that are circulating in Congress.
Register for our free email digests: